Journal of Advances in Nanomaterials
Novel Gelatin–Siloxane Nanoparticles Multiple Modified by Cationic Peptide and Aptamers as Efficient Gene Vector
Download PDF (829.1 KB) PP. 20 - 30 Pub. Date: March 3, 2017
Author(s)
- Xin-Hua Tian*
Department of Neurosurgery, Zhongshan Hospital, Xiamen University, Xiamen, China - Yu-Hua Wang
Department of Neurosurgery, Zhongshan Hospital, Xiamen University, Xiamen, China - Feng Wei
Department of Neurosurgery, Zhongshan Hospital, Xiamen University, Xiamen, China - Xiao-Ning Lin
Department of Neurosurgery, Zhongshan Hospital, Xiamen University, Xiamen, China - Lei Ren
Research Center of Biomedical Engineering, Department of Biomaterials, College of Materials; State Key Laboratory for Physical Chemistry of Solid Surfaces, Xiamen University, Xiamen, China
Abstract
Keywords
References
[1] Yi D, Hua TX, Lin HY, et al. Antitumor treatment efficacy by targeting epidermal growth factor receptor and vascular endothelial growth factor receptor-2 in an orthotopic human glioblastoma model. J Neurooncol. 2011; 104(1):93-101.
[2] Gwak HS, Youn SM, Kwon AH, et al. ACNU-cisplatin continuous infusion chemotherapy assalvage therapy for recurrent glioblastomas: phase II study. J Neurooncol. 2005;75(2):173–180.
[3] Liu L, Guo K, Lu J, et al. Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier. Biomaterials. 2008;29(10):1509-17.
[4] Chen YZ, Yao XL, Tabata Y, Nakagawa S, Gao JQ. Gene carriers and transfection systems used in the recombination of dendritic cells for effective cancer immunotherapy. Clin Dev Immunol. 2010;2010:565643.
[5] Vetrini F, Ng P.Gene therapy with helper-dependent adenoviral vectors: current advances and future perspectives. Viruses. 2010;2(9):1886-917.
[6] Fulci G, Chiocca EA.The status of gene therapy for brain tumors. Expert Opin Biol Ther. 2007;7(2):197-208.
[7] Tros de Ilarduya C, SunY, Düzgüne? N. Gene delivery by lipoplexes and polyplexes. Eur J Pharm Sci. 2010;40(3):159-70.
[8] Tian XH, Lin XN, Wei F, et al. Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles. Int J Nanomedicine. 2011;6:445–452.
[9] Kreuter J, Ulbrich K, Hekmatara T, Herbert E. Transferrin-and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood–brain barrier (BBB). Eur J Pharm Biopharm. 2009;71(2):251–256
[10] R. Fischer, M. Fotin-Mleczek, H. Hufnagel, R. Brock, Break on through to the other side-biophysics and cell biology shed light on cell-penetrating peptides, Chembiochem.2005;6(12):2126–2142.
[11] Ko HY, Choi KJ, Lee CH, Kim S.A multimodal nanoparticle-based cancer imaging probe simultaneously targeting nucleolin, integrin αvβ3 and tenascin-C proteins. Biomaterials. 2011;32(4):1130-8
[12] Wurster SE, Bida JP, Her YF, Maher 3rd LJ. Characterization of anti-NF-kappaB RNA aptamer-binding specificity in vitro and in the yeast three-hybrid system. Nucleic Acids Res. 2009;37(18):6214-6224.
[13] Li Y, Lee HJ, Corn RM. Fabrication and characterization of RNA aptamer microarrays for the study of protein-aptamer interactions with SPR imaging. Nucleic Acids Res. 2006;34(22):6416-6424.
[14] Midwood KS, Hussenet T, Langlois B, Orend G.Advances in tenascin-C biology. Cell Mol Life Sci. 2011;68(19):3175-99
[15] Kim MY, Kim OR, Choi YS, Lee H, Park K, Lee CT, Kang KW, Jeong S. Selection and characterization of tenascin C targeting peptide. Mol Cells. 2012;33(1):71-77
[16] Wang ZY., Zhao Y, Ren L, et al. Novel gelatin-siloxane nanoparticles decorated by Tat peptide as vectors for gene therapy[J]. Nanotechnology. 2008, 19(44):445103.
[17] Yin P, Wang J, Ren L, et al. Conjugation of membrane-destabilizing peptide onto gelatin-siloxane nanoparticles for efficient gene expression, Materials Science & Engineering C-Materials for Biological Applications.2010;30(8):1260-1265.
[18] Motegi H, Kamoshima Y, Terasaka S, et al. A novel adherent culture method of glioblastoma cells expressing CD133 using collagen-1-coated plates. Hokkaido Igaku Zasshi. 2012;87(4-5):147-151.
[19] Kurozumi K, Ichikawa T, Onishi M, et al. Cilengitide treatment for malignant glioma: current status and future direction. Neurol Med Chir (Tokyo). 2012;52(8):539-547.
[20] Wang L, Zhao H, Cui K, et al. Identification of novel small-molecule inhibitors of glioblastoma cell growth and invasion by high-throughput screening. Biosci Trends. 2012; 6(4):192-200.
[21] Ranki T, Hemminki A. Serotype chimeric human adenoviruses for cancer gene therapy. Viruses. 2010;2(10):2196-212.
[22] Hicke BJ , Stephens AW, Gould T, et al. Tumor targeting by an aptamer. The Journal Of Nuclear Medicine.2006,47(4):668–768.
[23] Hicke BJ, M arion C, Chang YF, et al. Tenascin-c aptamers are generated using tumor cells and purified protein. J Biol Chem. 2001;276:48644–48654.
[24] Daniels DA , C hen H, Hicke BJ, Swiderek KM, Gold L. A tenascin-c aptamer identified by tumor cell SELEX: systemat ic evolution of ligands by exponential enrichment. Proc Natl Acad Sci USA.2003;100(26):15416–15421.
[25] Eguchi, A., Akuta, T., Okuyama, H., et al. Protein transduction domain of HIV-1 TAT protein promotes efficient delivery of DNA into mammalian cells. J. Biol. Chem. 2001;276(28), 26204–26210.
[26] Agarwal A, Lariya N, Saraogi G, et al. Nanoparticles as novel carrier forbrain delivery: a review. Curr Pharm Des, 2009,15(8): 917-925.
[27] Zhi Ping Xu, Qing Hua Zeng, Gao Qing Lu, Ai Bing Yu. Inorganic nanoparticles as carriers for efficient cellular delivery. Chemical Engineering Science. 2006, 61,(3):1027–1040
[28] Paul A, Binsalamah ZM, Khan AA, et al. A nanobiohybrid complex of recombinant baculovirus and Tat/DNA nanoparticles for delivery of Ang-1 transgene in myocardial infarction therapy. Biomaterials. 2011;32(32):8304-8318.
[29] Lee SJ, Yoon SH, Doh KO. Enhancement of gene delivery using novel homodimeric tat peptide formed by disulfide bond. J Microbiol Biotechnol. 2011;21(8):802-807.
[30] Chung TH, Wu SH, Yao M, et al. The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. Biomaterials. 2007;28(19):2959-66.
[31] Liu L, Guo K, Lu J, et al. Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier. Biomaterials. 2008;29(10):1509-17.
[32] Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF. In vivo protein trans-duction: delivery of a biologically active protein into the mouse. Science. 1999;285(5433):1569-1572.
[33] Arjen van den Berg and Steven F Dowdy. Protein transduction domain delivery of therapeutic macromolecules. Current Opinion in Biotechnology. 2011, 22(6):888-893.
[34] Qin Y, Chen H, Yuan W, et al. Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery. Int J Pharm. 2011;419(1-2):85-95.